Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia

✍ Scribed by Giannopoulos, K; Dmoszynska, A; Kowal, M; Wąsik-Szczepanek, E; Bojarska-Junak, A; Rolinski, J; Döhner, H; Stilgenbauer, S; Bullinger, L

• Book ID: 109887133
• Publisher: Nature Publishing Group
• Year: 2009
• Tongue: English
• Weight: 340 KB
• Volume: 23
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2009.98